Cosmo Technologies secures FDA approval for Aemcolo to treat travelers’ diarrhea

Cosmo Technologies has achieved a significant milestone with the recent approval from the U.S. Food and Drug Administration (FDA) for its antibacterial drug, Aemcolo (rifamycin). ... Read More